ADVERTISEMENT

Pfizer

Now playing Next

Von der Leyen Commission loses COVID vaccine transparency case

ADVERTISEMENT

ADVERTISEMENT

TOP TAGS

OLYMPIC GAMES PARIS 2024 FRANCE PARIS OLYMPICS EUROPEAN UNION EUROPEAN PARLIAMENT WILDFIRES SNCF

More about this topic

Now playing Next

Have healthcare stocks been under the weather in 2023?

Euronews Business looks at how major healthcare stocks such as Pfizer and Moderna performed this year

29/12/2023

Now playing Next

WATCH: Tornado slams North Carolina homes and businesses

A tornado heavily damaged a major Pfizer pharmaceutical plant in North Carolina on Wednesday, the latest in a string of extreme weather events plaguing the US.

20/07/2023

Now playing Next

Moderna sues Pfizer-BioNTech for copying tech behind COVID vaccines

Moderna is suing its biggest rivals over claims they stole "groundbreaking technology" used in mRNA vaccines.

26/08/2022

Now playing Next

Commission's handling of text scandal is 'wake-up call': EU watchdog

The EU's Ombudsman upheld her finding of maladministration on Thursday over the Commission's handling of a journalist's request to see the texts exchanged between Ursula von der Leyen and the Pfizer CEO.

14/07/2022

ADVERTISEMENT

Now playing Next

EU ombudsman calls Commission response over texts 'problematic'

The case investigates the EU's purchase of COVID-19 vaccine contracts.

29/06/2022

Now playing Next

Moderna COVID vaccine approved by EU regulator for children aged 5-11

The European Medicines Agency also recommended booster shots for children aged 12 and older.

03/03/2022

Now playing Next

Von der Leyen text messages to Pfizer CEO 'should be released'

Critics say the European Commission has become less transparent, less accountable and "unhinged" from European democracy.

28/01/2022

Now playing Next

EMA approves Pfizer's anti-COVID pill for use in the EU

The antiviral drug Paxlovid reduced hospital admissions and deaths from COVID in at-risk people by up to 90 per cent, Pfizer said.

27/01/2022

Now playing Next

Pfizer/BioNTech to start clinical trials on new Omicron COVID vaccine

A new formulation of the COVID-19 jab based on the highly infectious Omicron variant is now in clinical trials, the drugmakers said on Tuesday

25/01/2022

Now playing Next

'Nocebo effect' cause of most COVID vaccine side effects, study says

Researchers say many of the common COVID vaccine side effects could actually be down to the "nocebo effect," the negative placebo effect.

19/01/2022

Now playing Next

Get ready for yearly COVID-flu combo vaccines, say Moderna and Pfizer

Vaccine maker Moderna predicted that its seasonal COVID and flu boosters would be available in some countries within the next two years.

18/01/2022

Now playing Next

Panama vaccinates children against Covid-19 amid surge in cases

Panama starts vaccinating children between the ages of five and eleven against Covid-19, in an effort to resume in-person learning at schools amid a new surge in cases.

08/01/2022

Now playing Next

This will impact your life

Brussels mulls joint EU purchase of new antiviral COVID pills

The European Commission is in talks with pharmaceutical companies to buy the antiviral pills, which can be taken orally at home.

05/01/2022

Now playing Next

US FDA expands Pfizer boosters for more teens amid Omicron surge

Boosters already are recommended for everyone 16 and older, and federal regulators on Monday decided they're also warranted for 12- to 15-year-olds once enough time has passed since their last dose.

03/01/2022

Now playing Next

Israel offers fourth vaccine dose to citizens aged 60 and over

Israel has been a pioneer in vaccinating its citizens against the coronavirus and began offering a third dose to citizens as early as last summer.

03/01/2022

Now playing Next

COVID vaccines are not enough for Omicron variant, warns BioNTech CEO

"We must be aware that even triple-vaccinated are likely to transmit the disease’” Ughur Sahin said, the CEO of the German company behind the mRNA vaccine produced with Pfizer.

20/12/2021

Now playing Next

Pfizer study finds its COVID pill reduces hospitalisation by nearly 90

The drugs manufacturer’s study on its COVID-19 oral antiviral found it reduced risk of hospitalisation or death by 89% within three days of symptom onset.

14/12/2021

Now playing Next

Pfizer says COVID booster offers protection against Omicron

"What we should really be reading into this is that any vaccine that boosts immunity will do the job," clinical expert Bharat Pankhania told Euronews.

08/12/2021

Now playing Next

Here’s what COVID vaccine makers are doing about the Omicron variant

COVID vaccine manufacturers are racing to develop new doses to combat the rising number of cases connected to the Omicron variant.

08/12/2021

Now playing Next

Pfizer to allow developing countries to make and sell its COVID pill

The new deal will mean that more than half the world's population will be able to access the treatment cheaply.

16/11/2021